Bayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis Ruchika Sharma23 Feb 2024 2:30 PM ISTBerlin: Bayer has announced the start of a Phase II clinical trial (SIRIUS study) with BAY3018250, an investigational first-in-class anti-alpha2...
German drugmaker Bayer cuts dividends to legal minimum to reduce debt Ruchika Sharma20 Feb 2024 2:50 PM ISTFrankfurt: German drugmaker Bayer said that it was amending its dividend policy to pay the legal minimum for a period of three years to reduce...
Bayer CEO says company stands behind glyphosate Ruchika Sharma11 Feb 2024 3:30 PM ISTFrankfurt: Bayer's CEO has said that the healthcare and crop chemicals group continues to firmly back its glyphosate weedkiller even after a...
Bayer says to outsource some aspects of pharma business in Africa Ruchika Sharma4 Feb 2024 3:15 PM ISTBayer will hand over the warehousing, distribution and sales representation of the medicines business, including for oncology and ophthalmology, to an...
Bayer ordered to pay USD 2.25 billion in latest Roundup trial Ruchika Sharma29 Jan 2024 12:30 PM ISTBayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller,...
Bayer application for regulatory approval of Aflibercept 8 mg accepted in China Ruchika Sharma26 Jan 2024 4:00 PM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) accepted the...
Bayer names Nelson Ambrogio as new head of Radiology business at pharmaceuticals division Ruchika Sharma25 Jan 2024 5:40 PM ISTBerlin: Bayer has announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024....
Bayer holds off on break up to focus on internal reorganisation for now: Sources Ruchika Sharma22 Jan 2024 11:30 AM ISTBayer AG will likely hold off on presenting break-up plans at an investor update scheduled for early March as CEO Bill Anderson prefers to focus...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Bayer's AskBio begins Phase II GenePHIT trial in Congestive Heart Failure Ruchika Sharma14 Jan 2024 11:30 AM ISTBerlin: Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer...
Bayer Eylea 8 mg approved in EU for treatment of two major retinal diseases Ruchika Sharma11 Jan 2024 3:30 PM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for new Eylea 8 mg...
Bayer wins latest Roundup cancer trial, ending losing streak Ruchika Sharma26 Dec 2023 2:00 PM ISTBayer has won a trial in a lawsuit brought by a California man who said he developed cancer from exposure to its Roundup weedkiller, ending what had...
